TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
AGEN

Agenus Inc

Healthcare · Biotechnology

8.30$ -16.1% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 35 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
24 84 28 24 25 27 24 26 30 34 34 35 133
52 67 3.5 37 41 34 22 27 24 7.5 0.6 15 47
-27 17 25 -13 -16 -7.1 2.4 -1.3 6.0 27 33 35 100
51 67 44 37 41 34 22 27 – 7.5 12 15 –
19 21 17 17 17 21 16 16 11 12 6.9 8.5 38
19 21 57 17 15 19 16 15 11 12 18 23 64
-46 -4.2 -33 -30 -32 -26 -13 -17 -4.5 14 15 11 36
19 44 29 32 36 21 13 13 13 16 15 15 59
-65 -49 -63 -55 -67 -47 -26 -30 64 -11 39 -0.6 92
17 -2.3 -1.6 -1.7 – – – – – – – – –
-62 -46 -62 -53 -66 -46 -25 -28 64 -11 39 -0.6 92
-43 0.8 -31 -20 -28 -23 -10 -14 80 6.0 54 15 156

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?